English
Swedish

Search

Sign in

Our products
- Why ASTar
  The ASTar system can provide correct treatment recommendation up to 48 hours faster than standard AST practice.
  Learn about ASTar
- ASTar kits – Cartridge and Disc for AST analysis directly from clinical samples
  - The global burden of sepsis
- Request consultation or get a quote
Innovation
- Innovation
  We’re constantly working to improve and explore new features to the ASTar system, as well as deliver new innovative solutions for faster infectious disease diagnostics to the market.
  Go to innovations
- Publications and posters
About us
- About us
  We are an innovative pioneer, that helps to save lives by ensuring antibiotics continue to be an effective treatment for future generations. We develop and deliver preferred solutions for healthcare providers, enabling them to accurately diagnose and treat infectious diseases in the shortest possible time. Our solutions help healthcare providers worldwide to reduce the use of antibiotics by providing optimal treatment information for each patient.
  Read more
- News and events
Investor relations
- Investor relations
  Information to the capital market about Q-linea, our operations and development
  Read more
- The share
- Financial Calendar
  - Reports and presentations
  - Press releases
- Corporate Governance
- IPO
Contact us
- Contact and directions
  We are always interested in hearing from you. Please contact us with any queries. Or if you just want to see more of our happy faces, find downloadable images of us in our image bank.
  Go to contact and directions
- Image bank
  - Whistleblowing
Career

Support zone
- Svenska
- English
Sign in

Support zone

Jonas Jarvius CEO & president presents at Redeye March 12, 2020

Jonas Jarvius CEO & president presents at Redeye March 12, 2020

Documents

Q-linea Redeye 20200312

Back to all news & events >

Q-linea is an
ISO 13485:2016 certified
company.

Contact us

Dag Hammarskjölds väg 52 A

SE-752 37 Uppsala

SWEDEN

Phone: +46 18 444 36 10

Subscribe

Get information about our current and upcoming products or subscribe to IR-related information.

Subscribe to newsletter IR-related information

Subscribe

Fill in the below information to keep up to date about our current and upcoming products.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

To subscribe, please read and approve our data storage policy to comply with GDPR.